Sponsor hub
H. Lundbeck A/S clinical trial failures
Review 34 stopped clinical trials from H. Lundbeck A/S, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OTHER/UNKNOWN
- 17
- OPERATIONAL
- 14
- EFFICACY/FUTILITY
- 2
- SAFETY
- 1
Notable sponsors
- H. Lundbeck A/S
- 34
Related phases
- Phase I
- 16
- Phase III
- 13
- Phase II
- 3
- Phase IV
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 34 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Healthy Participants trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
For strategic reasons
Phase IV Migraine trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated due to enrolment challenges.
Phase I Healthy trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
The study was terminated based on new safety data.
Phase I Multiple Sclerosis trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated for strategic reasons
Phase III Depression trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
The study was terminated based on new efficacy data from another study.
Phase III Depressive Disorder, Major trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
The study was terminated based on new efficacy data from another study.
Phase I Focal Epilepsy trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated due to enrolment challenges
Phase I Healthy Volunteers trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated for strategic reasons.
Phase I Fibromyalgia trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
Study terminated due to enrolment challenges.
Phase I Healthy trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated for strategic reasons.
Phase I Healthy trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New efficacy data from another study
Phase II Schizophrenia trial by H. Lundbeck A/S. Stop reason: EFFICACY/FUTILITY.
Lack of efficacy based on the interim analysis in the 17972A study
Phase II Schizophrenia trial by H. Lundbeck A/S. Stop reason: EFFICACY/FUTILITY.
Lack of efficacy based on interim analysis
Phase I Parkinson Disease trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
Study termination due to efficacy results of another study
Phase I Healthy trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
new safety data from another study
Phase I Alzheimer Disease trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New data: The study was terminated based on new efficacy data from another study
Phase III Treatment-resistant Schizophrenia trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New data; the study was terminated based on new efficacy data from another study
Phase I Alzheimer Disease trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New data: The study was terminated based on new efficacy data from another study
Phase I Alzheimer's Disease trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New data: The study was terminated based on new efficacy data from another study
Phase I Renal Failure trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
New data; the study was terminated based on new efficacy data
Phase III Major Depressive Disorder trial by H. Lundbeck A/S. Stop reason: SAFETY.
The study was terminated because the lead-in study (14571A) in elderly was terminated; see Detailed Description.
Phase III Major Depressive Disorder trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated because of recruitment challenges
Phase I Alzheimer's Disease trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated for strategic reasons.
Phase III Dravet Syndrome trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated due to recruitment challenges
Phase III Stroke trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol
Phase III Post-traumatic Stress Disorder trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
The study was terminated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns
Phase IV Alcohol Dependence trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated due to enrolment challenges
Phase I Bioequivalence trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
The study was withdrawn based on new efficacy data from another study
Phase III Schizophrenia trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
This study was withdrawn for administrative reasons. There were no safety concerns.
Phase III Dravet Syndrome trial by H. Lundbeck A/S. Stop reason: OPERATIONAL.
The study was terminated due to recruitment challenges
Phase II Primary Insomnia trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Primary Insomnia trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Primary Insomnia trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Insomnia trial by H. Lundbeck A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.